Standard BioTools

(NASDAQ) FLDM

Current PriceN/A

Market CapN/A

Since IPO (2011)-94%

5 Year-82%

1 Year-24%

1 Month-4%

Standard BioTools Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$64.76M

Net Income (TTM)

$74.90M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

FLDM News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Standard BioTools

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

389

CEO

Michael Egholm, PhD

Website

www.standardbio.com

Headquarters

South San Francisco, CA 94080, US

FLDM Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

-1%

Net Income Margin

-88%

Return on Equity

-18%

Return on Capital

-20%

Return on Assets

-13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$33.85M

Operating Income

$104.25M

EBITDA

$92.24M

Operating Cash Flow

$74.35M

Capital Expenditure

$8.30M

Free Cash Flow

$82.65M

Cash & ST Invst.

$187.57M

Total Debt

$30.83M

Standard BioTools Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$17.35M

-121.4%

Gross Profit

$6.00M

-115.7%

Gross Margin

34.59%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

615

N/A

Net Income

$19.28M

+122.6%

EBITDA

$16.64M

+83.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$156.75M

-39.7%

Accounts Receivable

$13.43M

-60.0%

Inventory

$19.98M

-51.0%

Long Term Debt

$25.34M

-5.3%

Short Term Debt

$5.49M

-11.8%

Return on Assets

-13.19%

N/A

Return on Invested Capital

-20.31%

N/A

Free Cash Flow

$1.67M

+98.6%

Operating Cash Flow

$1.20M

+98.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TRHCTabula Rasa HealthCare, Inc.

TRHCTabula Rasa HealthCare, Inc.$10.50+0.86%

SCPHscPharmaceuticals Inc.

SCPHscPharmaceuticals Inc.$5.67+0.00%

LFCRLifecore Biomedical, Inc.

LFCRLifecore Biomedical, Inc.$4.94-3.52%

ALIMAlimera Sciences, Inc.

ALIMAlimera Sciences, Inc.$5.54-0.18%

THRDThird Harmonic Bio, Inc.

THRDThird Harmonic Bio, Inc.$5.38-0.09%

INZYInozyme Pharma, Inc.

INZYInozyme Pharma, Inc.$4.00+0.25%

CLYMClimb Bio, Inc.

CLYMClimb Bio, Inc.$8.78-5.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.46+0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

INTCIntel

INTCIntel$94.75+0.12%

FFord Motor Company

FFord Motor Company$12.24-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.08-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.93-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

Questions About FLDM

What is the current price of Standard BioTools?

Standard BioTools is trading at N/A per share.

What is the 52-week range for Standard BioTools?

Over the past 52 weeks, Standard BioTools has traded between N/A and N/A.

How much debt does Standard BioTools have?

As of the most recent reporting period, Standard BioTools reported total debt of $30.83M.

How much cash does Standard BioTools have on hand?

Standard BioTools reported $120.86M in cash and cash equivalents in its most recent financial results.

What is Standard BioTools’s dividend yield?

Standard BioTools does not currently have a dividend yield.

Standard BioTools

Standard BioTools Financials at a Glance

FLDM News

Why Fluidigm Stock Is Sinking Today

Why Fluidigm Stock Is Flying Higher Today

Is This Market Correction the Right Time to Buy Fluidigm?

Fluidigm's Saliva Coronavirus Test Being Run by 2 Certified Labs

Why Shares of These 3 Coronavirus-Test Makers Saw Big Moves in August

Why Fluidigm Stock Plunged Today

Nasdaq Falls 40; Fulgent, Fluidigm Collapse on COVID-19 Competition

Why Fluidigm Stock Surged Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Standard BioTools

FLDM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Standard BioTools Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FLDM

What is the current price of Standard BioTools?

What is the 52-week range for Standard BioTools?

How much debt does Standard BioTools have?

How much cash does Standard BioTools have on hand?

What is Standard BioTools’s dividend yield?

Premium Investing Services